logo
15:55 Feb 25

Kopran Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
129.77
+1.15 (+0.89%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Kopran Ltd. Financials

Kopran Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
129.77
+1.15 (+0.89%)
15:55 Feb 25
Quality
image/svg+xml

46/100
Medium Financial Strength

Valuation
image/svg+xml

46/100
Mid Valuation

Technical

28/100
Technically Bearish

Strength

5

Weakness

5

Opportunity

0

Threats

0

7.43 %

ROE %

4.56 %

ROA %

3.43

EPS

107.35

BVPS

6.12 %

Net Profit Margin

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales
491.81 477.52 550.99 614.59 629.6
Operating Expenses +
410.03 390.13 499.2 540.18 556.71
Raw Material
286.27 300.56 345.95 400.88 410.66
Increase Decrease in Cost
15.52 -29.19 12.62 1.06 -6.04
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
37.16 43.27 49.95 52.28 60.54
Miscellaneous Expenses
112.72 81.95 139.36 98.02 110.87
Operating Profit
81.78 87.39 51.79 74.41 72.89
Other Income
17.99 10.6 3.06 14.61 3.98
Depreciation
10.19 11.1 12.71 12.89 15.59
Interest
6.24 5.12 6.08 8.59 9.34
Profit before tax and exceptio..
83.34 81.78 36.07 67.54 51.95
Exceptional Items
0 0 0 0 0
PBT
83.34 81.78 36.07 67.54 51.95
Provision for Taxation
21.73 20.75 8.83 16.59 13.4
Net Profit
61.61 61.03 27.23 50.96 38.55
NET Profit after MI
61.61 61.03 27.23 50.96 38.55
EPS
14.24 13.77 5.65 10.57 7.99
Operating Profit Margin (%)
16.63 18.3 9.4 12.11 11.58
Net Profit Margin (%)
12.53 12.78 4.94 8.29 6.12

Kopran Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Promoter 44.40 44.40 44.40 44.40 44.50 44.50
FII 0.40 0.60 0.80 1.10 0.90 1.30
Public 0.00 0.00 0.00 0.00 0.00 0.20
Others 55.20 55.00 54.80 54.50 54.60 54.00
Shareholder Shares Holding %
Research 360 logo
Download Our App On: